Pancreatic Neuroendocrine Tumor incidentally found on 68Ga-PSMA PET/CT
Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PCa) epithelial cells as well as the tumor neovascularity many other neoplasms. We present a case of a 67-year-old man with biochemically recurrent PCa who underwent 68Ga-PSMA-11 PET/CT, which demonstrated an intensely radiotracer-avid pancreatic neuroendocrine tumor. This case demonstrates the equivocal nature of pancreatic lesions, and reinforces the need for further work-up of unusual patterns of uptake, on PSMA-targeted PET/CT. The differential diagnosis of a radiotracer-avid pancreatic lesion should include primary malignancies, among them adenocarcinoma and neuroendocrine tumors.
Authors
- Elie Saad (ORCID: https://orcid.org/0000-0002-2220-929X)
- Daniel A. Laheru (ORCID: https://orcid.org/0000-0001-6646-0200)
- Eun Ji Shin (ORCID: https://orcid.org/0000-0003-0624-8149)
- Mark Christopher Markowski (ORCID: https://orcid.org/0000-0003-2780-5100)
- Chen Lossos
- Steven P. Rowe (ORCID: https://orcid.org/0000-0003-2897-4694)
- Rodrigo Luna (ORCID: https://orcid.org/0000-0002-8463-9279)
- M. Robinson
Institutions
- University of North Carolina at Chapel Hill (US)
- Johns Hopkins University (US)
Publication Details
- Journal
- Nuklearmedizin - NuclearMedicine
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1055/a-2511-6595
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00